P. Musto
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 10
- Acute Myeloid Leukemia Research 1
- Oncology 7
- Cancer Treatment and Pharmacology 4
- Peptidase Inhibition and Analysis 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Narasimhan P. Agaram (1 shared paper)Rutika Mehta (1 shared paper)Sunil Badve (1 shared paper)Muhammad T. Idrees (1 shared paper)Thomas M. Ulbright (1 shared paper)Kurt Hodges (1 shared paper)Eyas M. Hattab (1 shared paper)Steven P. Treon (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Bone Marrow Transplantation (1 paper)Clinical Cancer Research (1 paper)Haematologica (1 paper)Journal of the Peripheral Nervous System (1 paper)
- Partner nations
- United States
In The Last Decade
P. Musto
18 papers receiving 224 citations
Peers
Comparison fields: 5 of 41
- Genetics 94
- Hematology 75
- Pathology and Forensic Medicine 87
- Health Informatics 2
- Oncology 33
Countries citing papers authored by P. Musto
This map shows the geographic impact of P. Musto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Musto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Musto more than expected).
Fields of papers citing papers by P. Musto
This network shows the impact of papers produced by P. Musto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Musto. The network helps show where P. Musto may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Musto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 89 | |
| 2 | 2011 | 85 | |
| 3 | TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS | 2003 | 12 |
| 4 | 2002 | 8 | |
| 5 | 1994 | 7 | |
| 6 | Secondary malignancies in elderly myeloma patients | 2011 | 6 |
| 7 | 2004 | 6 | |
| 8 | [An unusual case of postoperative mechanical obstruction of the upper respiratory tract in a child]. | 1977 | 3 |
| 9 | Autologous stem cell transplantation (ASCT) vs ASCT followed by reduced-intensity conditioning allogeneic SCT with identical sibling donor in previously untreated multiple myeloma: preliminary analysis of a prospective controlled trial by the EBMT | 2008 | 2 |
| 10 | 2019 | 2 | |
| 11 | 2010 | 2 | |
| 12 | 2010 | 2 | |
| 13 | Low-dose thalidomide and dexamethasone improves survival in advanced multiple myeloma | 2002 | 1 |
| 14 | A RANDOMIZED PHASE II STUDY (GISL-MM03 TRIAL) WITH ORAL MELPHALAN plus PREDNISONE (MP) VERSUS MELPHALAN, plus PREDNISONE plus THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA | 2009 | 1 |
| 15 | 2011 | 1 | |
| 16 | INTERMEDIATE-DOSE MELPHALAN (100MG/M2), THALIDOMIDE, DEXAMETHASONE AND STEM CELL SUPPORT IN PATIENTS WITH REFRACTORY OR RELAPSED MYELOMA | 2006 | 1 |
| 17 | 2010 | 1 | |
| 18 | IN MYELOMA PATIENTS TREATED WITH MELPHALAN 100mg/m2 OR MELPHALAN 200mg/m2 OUTCOME IS NOT SIGNIFICANTLY DIFFERENT | 2000 | 1 |
About P. Musto
P. Musto is a scholar working on Hematology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 18 papers that have together received 230 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), HIV/AIDS drug development and treatment (2 papers), Peptidase Inhibition and Analysis (2 papers), HER2/EGFR in Cancer Research (2 papers), Acute Myeloid Leukemia Research (1 paper) and Pneumothorax, Barotrauma, Emphysema (1 paper). The work is most often cited by research in Genetics (94 citations), Hematology (75 citations), Pathology and Forensic Medicine (87 citations), Health Informatics (2 citations) and Oncology (33 citations). P. Musto has collaborated with scholars based in United States. Frequent co-authors include Narasimhan P. Agaram, Rutika Mehta, Sunil Badve, Muhammad T. Idrees, Thomas M. Ulbright, Kurt Hodges, Eyas M. Hattab, Steven P. Treon, Kenneth C. Anderson and Johannes C. Nunnink. Their work appears in journals such as Journal of Clinical Oncology, Bone Marrow Transplantation, Clinical Cancer Research, Haematologica and Journal of the Peripheral Nervous System.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.